Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLTR COULTER PHARMACEUTICAL -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (200)	4/1/1999 4:04:00 PM
From: Pseudo Biologist	Respond to of 666

David, check this link and the ones "around it": Message 5509761 In short, this still looks pretty early stage. PB

To: LLCF who wrote (200)	4/1/1999 4:27:00 PM
From: scaram(o)uche	Respond to of 666

valuable research infrastructure working on tumor-activated drugs, but..... the pipe is not much of a factor..... they are a merger candidate and they know such. look at the intraday, and note that we closed unchanged with the bid above the last trade...... some fund, run by a jerk, in trouble and bailing in the morning. Perhaps it was a portfolio manager who decided that AMGN looks good at this market cap. iqc.com as I recently suggested in another thread, one should choose a strategy and fight back against the jerks. I look for these unexplained and irrational "bails", and buy calls for intraday trading. DAK.... I've noticed that you aren't standing still, presenting a target. The "choose a strategy and fight back" comment was for the thread, in light of this morning's precipitous fall. Nice work with CEPH.